2/21/2024 | BKIG | Life sciences business of PerkinElmer, Inc. is now Revvity, Inc.
|
8/9/2022 | BKIG | S&P turns PerkinElmer view to stable
|
9/9/2021 | IG | New Issue: PerkinElmer sells $2.3 billion of notes due 2023, 2024, 2028, 2031
|
9/8/2021 | BKIG | S&P gives BBB to PerkinElmer notes
|
9/8/2021 | BKIG | Fitch assigns BBB to PerkinElmer notes
|
9/8/2021 | IG | PerkinElmer to conduct four-tranche note offering for acquisition; talk emerges
|
9/8/2021 | IG | PerkinElmer to conduct four-tranche note offering for acquisition
|
8/12/2021 | BK | PerkinElmer gets $500 million delayed-draw loan for BioLegend purchase
|
7/26/2021 | BKIG | S&P shifts PerkinElmer view to negative
|
7/26/2021 | BKIG | PerkinElmer secures bridge financing to acquire BioLegend
|
6/9/2021 | BKIG | Moody's alters PerkinElmer view to positive
|
3/4/2021 | IG | New Issue: PerkinElmer prices $800 million senior notes due 2031, 2051
|
3/4/2021 | BKIG | Moody's gives PerkinElmer's notes Baa3
|
3/4/2021 | IG | PerkinElmer plans to sell 10-, 30-year senior notes; talk emerges
|
3/4/2021 | BKIG | S&P assigns PerkinElmer notes BBB
|
3/4/2021 | BKIG | Fitch rates PerkinElmer notes BBB
|
3/4/2021 | IG | PerkinElmer plans senior notes in two parts via three bookrunners
|
7/31/2020 | BKIG | S&P revises PerkinElmer view to stable
|
9/17/2019 | BK | PerkinElmer gets $1 billion revolver at Libor plus 79.5-142.5 bps
|
9/13/2019 | IGLM | PerkinElmer plans redemption of 5% notes due 2021 via new issue
|
9/11/2019 | EMHYPFPV | Market Commentary: IG primary slows; Expedia is selling $1.25 billion 2030 notes; FHLB to price $600 million add-on
|
9/11/2019 | IG | Market Commentary: IG primary slows; Expedia is selling $1.25 billion 2030 notes; FHLB to price $600 million add-on
|
9/11/2019 | IG | Market Commentary: Morning Commentary: IG primary slows; Sumitomo pricing emerges; FHLB add-on on tap
|
9/11/2019 | IG | New Issue: PerkinElmer gives details on $850 million 3.3% 10-year senior notes
|
9/10/2019 | IG | Market Commentary: Ford Motor gets cut to junk by Moody’s; Hospitality Properties, Prudential Financial, KfW price
|
9/10/2019 | IG | New Issue: PerkinElmer prices $850 million 3.3% 10-year senior notes at 99.67
|
9/10/2019 | BK | PerkinElmer plans new $1 billion revolver, eyes making paydown first
|
9/10/2019 | IGLM | PerkinElmer considers redeeming 5% notes due 2021 via new issue
|
9/10/2019 | BKIG | Fitch rates PerkinElmer’s notes BBB
|
9/10/2019 | BKIG | S&P assigns PerkinElmer notes BBB
|
9/10/2019 | BKIG | Moody’s rates PerkinElmer notes Baa3
|
9/10/2019 | IG | PerkinElmer intends to price senior notes via two bookrunners
|
9/6/2019 | BKIG | Fitch revises PerkinElmer view to negative
|
5/7/2019 | BKIG | S&P lowers PerkinElmer view to negative
|
9/25/2018 | BKIG | Fitch affirms PerkinElmer
|
4/11/2018 | BK | PerkinElmer to repay term loan, some revolver debt via new notes
|
4/4/2018 | BKIG | Fitch gives BBB to PerkinElmer notes
|
4/4/2018 | BKIG | S&P rates PerkinElmer notes BBB
|
4/4/2018 | BKIG | Moody’s gives PerkinElmer notes Baa3
|
8/15/2017 | BK | PerkinElmer enters $200 million 364-day term loan, amends revolver
|
6/19/2017 | BKBWIG | PerkinElmer taps undrawn revolver for $1.3 billion EuroImmun purchase
|
8/16/2016 | BKIG | Fitch rates PerkinElmer revolver BBB
|
8/12/2016 | BK | PerkinElmer enters into upsized five-year $1 billion revolver
|
7/13/2016 | BKIG | Moody’s applies Baa3 to PerkinElmer bond
|
7/12/2016 | BKIG | S&P gives PerkinElmer notes BBB
|
7/12/2016 | BKIG | Fitch rates PerkinElmer notes BBB
|
7/12/2016 | BK | PerkinElmer to reduce credit facility borrowings via new note offering
|
9/17/2015 | BKCVIG | Fitch upgrades PerkinElmer
|
9/18/2014 | BKCVIG | Fitch lifts PerkinElmer view to positive
|
5/27/2014 | IG | Moody's changes PerkinElmer outlook to stable
|
1/10/2014 | BK | PerkinElmer enters into $700 million unsecured revolving facility
|
11/26/2013 | IGLM | PerkinElmer to redeem $150 million 6% senior notes due 2015 on Dec. 26
|
12/21/2011 | BK | PerkinElmer enters $700 million five-year revolving credit facility
|
10/25/2011 | IG | S&P: PerkinElmer notes BBB
|
10/21/2011 | IG | Moody's assigns PerkinElmer notes Baa3
|
10/21/2011 | IG | Market Commentary: Primary volume expected to pick up mid-month; deals trade better as bank CDS costs tighten
|
10/20/2011 | IG | New Issue: PerkinElmer sells upsized $500 million 5% 10-year notes at Treasuries plus 290 bps
|
10/20/2011 | IG | Market Commentary: Sonoco, PerkinElmer, Pernod Ricard sell on momentum; financials widen; new bonds firm
|
10/18/2011 | IG | Fitch rates PerkinElmer loans BBB-
|
10/18/2011 | IG | Moody's affirms PerkinElmer
|
10/17/2011 | HYIG | S&P affirms PerkinElmer
|
9/8/2011 | HYIG | Moody's may cut PerkinElmer
|
9/8/2011 | HYIG | S&P: PerkinElmer on watch
|
3/25/2011 | IG | Moody's: PerkinElmer unchanged
|
9/1/2010 | HYIG | Illumination and Detection Solutions to help fund sale with $90 million of mezzanine debt
|
9/1/2010 | PV | Illumination and Detection sale includes $90 million of mezzanine debt
|
4/7/2010 | CVIGPF | PerkinElmer files automatic shelf covering stock, preferreds and debt
|
11/15/2007 | SS | PerkinElmer acquires ViaCell
|
11/9/2007 | SS | PerkinElmer completes offer for ViaCell
|
10/25/2007 | SS | PerkinElmer clears waiting period hurdle in tender for ViaCell
|
10/12/2007 | SS | PerkinElmer subsidiary starts cash tender offer for ViaCell
|
10/3/2007 | IG | Moody's affirms PerkinElmer
|
10/2/2007 | IG | S&P: PerkinElmer unchanged
|
9/5/2007 | IG | Moody's rates PerkinElmer facility Baa3
|
8/10/2007 | IG | S&P upgrades PerkinElmer
|
11/8/2006 | BT | Merrill reinstates PerkinElmer at neutral
|
7/24/2006 | BT | PerkinElmer to collaborate on discovery of biomarkers in cancer laboratories
|
5/1/2006 | BT | PerkinElmer acquires Spectral Genomics
|
4/28/2006 | BT | Merrill reiterates PerkinElmer at buy
|
3/28/2006 | BT | PerkinElmer, George Mason University to develop proteomic technologies, cancer biomarkers
|
1/27/2006 | BT | Merrill gives PerkinElmer buy rating
|
12/22/2005 | BT | PerkinElmer maintained by Merrill at buy
|
11/23/2005 | HY | PerkinElmer receives tenders for $269.975 million 8 7/8% notes
|
11/11/2005 | BT | Merrill Lynch maintains PerkinElmer at buy
|
11/8/2005 | HY | PerkinElmer sets pricing, gets required consents for 8 7/8% notes
|
11/1/2005 | BKBTHY | S&P ups PerkinElmer, rates loan BBB-
|
11/1/2005 | BK | PerkinElmer gets $350 million unsecured revolver
|
11/1/2005 | BKBTHY | Moody's rates PerkinElmer revolver Baa3, ups notes to Ba1
|
10/31/2005 | BT | Merrill Lynch maintains Perkin Elmer earnings estimates
|
10/26/2005 | BT | Merrill maintains PerkinElmer at buy
|
10/25/2005 | HY | PerkinElmer tenders for 8 7/8% notes
|
10/7/2005 | BT | Merrill Lynch keeps PerkinElmer's buy rating
|
7/27/2005 | BT | Perkin Elmer kept by Merrill Lynch at buy
|
5/24/2005 | BKHY | Moody's lifts PerkinElmer
|
4/13/2005 | BKHY | S&P: PerkinElmer up to positive
|
2/28/2005 | BKHY | Moody's may up PerkinElmer
|
10/26/2004 | BKHY | PerkinElmer amends loan to permit note repurchase, increase restricted payments allowances
|
10/12/2004 | BKHY | Moody's: PerkinElmer positive
|
10/11/2004 | CV | Moody's: PerkinElmer outlook positive
|
12/31/2003 | CV | Alkermes says 98.4% of convertibles tendered, sells $60 million new notes
|
12/31/2003 | HY | Sinclair completes 83/4% '07 notes tender; calls outstanding remnant
|
12/9/2003 | BKCVHY | Fitch affirms PerkinElmer senior debt BB+
|
6/20/2003 | CV | Lattice calls 43/4% convertibles
|
1/17/2003 | BK | Market Commentary: Alpha Natural Resources $110 million revolver meeting sees better-than-expected attendance
|
12/20/2002 | CV | Moody's puts Semco on review
|
12/20/2002 | HY | Moody's cuts Terex
|
12/20/2002 | BK | Moody's cuts Terex
|
12/19/2002 | BK | Market Commentary: Vanguard Health breaks around par on Thursday in week of multiple loans entering secondary
|
12/17/2002 | BK | Market Commentary: Hercules shows strength as new loan breaks into the secondary at par plus levels
|
12/16/2002 | HY | Market Commentary: Hollinger, Iron Mountain price deals as activity pace slows
|
12/13/2002 | HY | New Issue: PerkinElmer 10-year notes upsized to $300 million, yield 9%
|
12/13/2002 | HY | Market Commentary: Biggest day for new deals in 19 months; AES bonds jump on tender offer completion
|
12/12/2002 | HY | PerkinElmer $225 million 10-year notes talked at 9%-91/4%, pricing Friday
|
12/12/2002 | HY | Market Commentary: PCS firms off as Sprint sprints away from woes; fund inflows end; add-on deal parade continues
|
12/11/2002 | BK | S&P puts Hollinger on watch, rates new loan BB-, notes B
|
12/11/2002 | CV | S&P rates Baxter mandatory A
|
12/11/2002 | HY | S&P puts Hollinger on watch, rates new loan BB-, notes B
|
12/10/2002 | BK | Moody's cuts Navistar
|
12/10/2002 | CV | Fitch rates Baxter mandatory A
|
12/10/2002 | HY | Moody's cuts Navistar
|
12/9/2002 | HY | Comdisco Holding to redeem some 11% '05 notes
|
12/4/2002 | BK | Market Commentary: Sanmina-SCI bank meeting set for Thursday, Hughes closes $1.9 billion
|
12/3/2002 | BK | Market Commentary: PerkinElmer launches new $545 million credit facility
|
12/2/2002 | BK | Market Commentary: Nextel trades in quiet market; Charter bank debt strengthens by about 50 basis points
|
12/2/2002 | CV | PerkinElmer starts tender for 0% convertibles due 2020
|
12/2/2002 | HY | PerkinElmer $225 million 10-year notes set to price week of Dec. 16
|
12/2/2002 | HY | Market Commentary: UAL bonds gyrate as mechanics throw plans into turmoil; Allegiance Telecom up on debt plans
|
11/22/2002 | HY | PerkinElmer tenders for 6.80% '05 notes
|
11/19/2002 | BK | S&P cuts Aquila to junk
|
11/19/2002 | CV | S&P cuts AMD, rates convert CCC
|
11/19/2002 | HY | S&P cuts Aquila to junk
|
10/31/2002 | CV | Market Commentary: Firm tone on rising confidence; Allergan prices $450 million, Lucent, EDS active
|
10/30/2002 | HY | S&P puts PerkinElmer on watch
|
10/30/2002 | BK | S&P puts PerkinElmer on watch
|
10/30/2002 | CV | S&P puts PerkinElmer on watch
|
10/29/2002 | BK | Market Commentary: Sprint PCS affiliate paper drops, NDCHealth, PerkinElmer plan deals
|
10/29/2002 | BKCVHY | PerkinElmer plans $445 million credit facility, $225 million notes to redeem LYONs
|
10/29/2002 | HY | Market Commentary: OM Group dives on loss, earnings warning, NDCHealth, PerkinElmer join calendar
|
10/10/2002 | CV | Bear Stearns see PerkinElmer put getting paid via capital markets or banks
|
9/20/2002 | BK | S&P cuts WCI Steel
|
9/20/2002 | CV | Fitch ups AmeriSourceBergen outlook
|
9/19/2002 | BK | PerkinElmer amends loan, modifying covenants, rates and borrowing base
|
8/15/2002 | CV | S&P cuts Six Flags outlook
|
8/15/2002 | CV | Market Commentary: Market searches for yield, but still leery of creditworthiness
|
8/12/2002 | BK | PerkinElmer sees possibility of non-compliance with interest coverage covenant
|
8/12/2002 | BK | Fitch cuts Qwest
|
8/12/2002 | CV | Fitch cuts PerkinElmer to junk
|
8/12/2002 | HY | Fitch cuts Qwest
|
7/19/2002 | CV | Bear Stearns finds few short put convertibles yielding more than PerkinElmer
|
5/31/2002 | CV | S&P rates new TXU issue at BBB
|
5/23/2002 | CV | S&P keeps WorldCom on negative watch
|
5/1/2002 | CV | Moody's downgrades Xerox
|
3/18/2002 | CV | S&P keeps Tyco on developing watch
|